InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Saturday, 05/23/2020 7:25:23 AM

Saturday, May 23, 2020 7:25:23 AM

Post# of 691048
Very good that no warrants can be exercised before november. So the share price has sufficient room to move on positive P3 results, the acceptance from all regulatory agencies to accept and give the exact timeline to judge on commercial use, and release the news for partnerships and/or buyout.
No room for naked shorts till November.
PT on positive P3 results = $3-5/share or a MC of $2b-3,4b
Because of filing for commercial approval in the US,Canada and entire Europe. Because of higher possibilities of success for DcVax direct. And because it is very attractive to combine with other cancer treatments from big pharma companies.
My guess:
NWBO will be bought by Merck or BMS
CVM will be bought by TEVA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News